Cite
HARVARD Citation
Bai, H. et al. (2020). EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma. Journal for immunotherapy of cancer. 8 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bai, H. et al. (2020). EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma. Journal for immunotherapy of cancer. 8 (2), p. . [Online].